Good Morning! Latin America: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Good Morning! Latin America.

Press releases published on June 29, 2026

Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
Achieve Life Sciences Joins Russell 2000® Index
Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis
Oncotelic Announces Peer-Reviewed Validation of Deciparticle™ Platform Supporting Clinical Development of Sapu003
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes
Replimune Reports Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update
Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength
Latin Metals Reports High-Grade Gold Results at La Flora
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
Forte Minerals Anchors Capital Structure with C$1.47M Treasury Influx; Highlights Tight Share Structure and Strategic Ownership Base
Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET
BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility
Koryx Copper Provides Further Drill Results for the Haib Copper Project in Southern Namibia
NexGold Announces Closing of C$10 Million Private Placement of Flow-Through Shares
Helium Evolution Announces Saskatchewan Land Tenure Cost Savings, Adjacent Crown Land Sale Results, and OTCQB Listing
Golar LNG Limited – Q2 2026 results presentation
Nova Minerals Announces Korbel Floatation Test-work Produces High-Grade Gold Concentrate up to 26.7 g/t Au with Consistent Recoveries Exceeding 95%
Zymeworks to Acquire Theravance Biopharma, Inc.
Resalis Announces Initiation of Phase 1b Clinical Study  Evaluating RES-010 as Treatment to Address Unmet Needs in Obesity

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Good Morning! Latin America

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.